Ruark 2019 top news

  • How much is 1% A/E improvement worth to you? As you can see, we estimate that it can be hundreds of millions or even billions, but we recommend that you do the math for yourself. And yes, this 1%+ is what we can typically do using the data from our VA and FIA industry studies of policyholder behavior (over $1 trillion current account value) in a credibility-based predictive analytics framework. If you are aware of a better cost-benefit anywhere, we'd love to hear about it! We're trying to make it as easy as possible for you to fend off the budget hawks.

 

  • VM-21 exposure draft looks set to raise the bar on policyholder behavior data analysis and modeling assumptions. Fortunately, we've got you covered there too.

 

  • 2019 FIA and VA studies are still available for purchase, along with our most recent (triennial) 2018 mortality studies, if you have not done so already.

Other goodies --

  • Data gathering is in flight for 2020 FIA studies and we will turn to VA data after year-end. And we are working to bring some new data contributors aboard too. If you're not in yet, let's fix that.

 

  • As previously mentioned, we also plan to gather data in H1 2020 for a first ever GMIB post-annuitization mortality study. Longevity anti-selection? Comparisons to GLWBs or SPIAs? We want to know too, and the data is now emerging.

 

  • Looking ahead to 2020, our plans are here.  The industry studies feed into our more customized engagements which range from assumption review to development of predictive models and related assumptions to complete process management.

 

 

Please contact me if you would like to discuss.